Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

Fig. 4

Clinical trials in MSC therapy for COVID-19 registered in ClinicalTrials.gov (January 2021). This graph presents the distribution of MSC-based clinical trials for COVID-19 treatment based on cell source (a), study phase (b), number of participants (c), and study locations (d). Mesenchymal stem/stromal cell (MSC); coronavirus disease 2019 (COVID-19); bone marrow (BM); adipose tissue (AT); umbilical cord (UC); Wharton’s jelly (WJ)

Back to article page